These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 25883259)
1. Sudden cardiac arrest secondary to cardiac amyloidosis in a young woman with cryopyrin-associated periodic syndrome. Endo K; Suzuki A; Sato K; Shiga T BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25883259 [TBL] [Abstract][Full Text] [Related]
2. A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors. Bertoni A; Carta S; Baldovini C; Penco F; Balza E; Borghini S; Di Duca M; Ognio E; Signori A; Nozza P; Schena F; Castellani P; Pastorino C; Perrone C; Obici L; Martini A; Ceccherini I; Gattorno M; Rubartelli A; Chiesa S J Allergy Clin Immunol; 2020 Jan; 145(1):368-378.e13. PubMed ID: 31194989 [TBL] [Abstract][Full Text] [Related]
3. Canakinumab for the treatment of cryopyrin-associated periodic syndromes. Walsh GM Drugs Today (Barc); 2009 Oct; 45(10):731-5. PubMed ID: 20069137 [TBL] [Abstract][Full Text] [Related]
4. Renal and thyroid amyloidosis secondary tocryopyrin-associated periodic syndrome(Muckle-Wells syndrome) (NLRP3 mutation). Bolaños L; Mosquera-Reboredo JM; Cao M; Ferreiro T; Veleiro B; Valdés F; Vázquez-Martul E Nefrologia; 2013; 33(2):266-71. PubMed ID: 23511763 [No Abstract] [Full Text] [Related]
5. AA amyloidosis complicating cryopyrin-associated periodic syndrome: a study of 86 cases including 23 French patients and systematic review. Rodrigues F; Cuisset L; Cador-Rousseau B; Giurgea I; Neven B; Buob D; Quartier P; Hachulla E; Lequerré T; Cam G; Boursier G; Hervieu V; Grateau G; Georgin-Lavialle S Rheumatology (Oxford); 2022 Nov; 61(12):4827-4834. PubMed ID: 35262642 [TBL] [Abstract][Full Text] [Related]
6. Two adult siblings with atypical cryopyrin-associated periodic syndrome due to a novel M299V mutation in NLRP3. Verma D; Eriksson P; Sahdo B; Persson A; Ejdebäck M; Särndahl E; Söderkvist P Arthritis Rheum; 2010 Jul; 62(7):2138-43. PubMed ID: 20506209 [TBL] [Abstract][Full Text] [Related]
7. Novel evidences of atypical manifestations in cryopyrin-associated periodic syndromes. Bujan-Rivas S; Basagaña M; Sena F; Méndez M; Dordal MT; Gonzalez-Roca E; Ruiz-Ortiz E; Mensa-Vilaró A; Plaza S; Modesto C; Ordi-Ros J; Yagüe J; Martínez-Valle F; Aróstegui JI Clin Exp Rheumatol; 2017; 35 Suppl 108(6):27-31. PubMed ID: 28079503 [TBL] [Abstract][Full Text] [Related]
8. A novel mutation in the CIAS1/NLRP3 gene associated with an unexpected phenotype of cryopyrin-associated periodic syndromes. Insalaco A; Prencipe G; Buonuomo PS; Ceccherini I; Bracaglia C; Pardeo M; Nicolai R; De Benedetti F Clin Exp Rheumatol; 2014; 32(1):123-5. PubMed ID: 24144430 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort. Anton J; Calvo I; Fernández-Martin J; Gamir ML; Merino R; Jimenez-Treviño S; Sevilla B; Cabades F; Bou R; Arostegui JI Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S67-71. PubMed ID: 26243511 [TBL] [Abstract][Full Text] [Related]